Iron-deficiency Anemia
29
3
4
14
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
13.8%
4 terminated out of 29 trials
77.8%
-8.7% vs benchmark
28%
8 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (29)
Pediatric Outcomes and Recovery With Peri-Operative Iron Supplement Evaluation
Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy
Oral Iron Supplementation for Patients With Chronic Kidney Disease
Impact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 Months
Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
Endoscopy in CKD With Iron Deficiency Anemia
Neurovascular Complications and White Matter Damage in Acquired Anemias
Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
EHR-based Patient Identification and Panel Management of Patients With Iron Deficiency Anemia
Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Use of Cast Iron Pots to Improve Maternal Anemia
Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia
The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers
Umbilical Cord Clamping and Infant Iron Status
Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
Lactoferrin Supplementation and Iron Metabolism in Healthy Pregnant Women
IHAT Absorption Kinetics
Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia